Scientific letters

• Cardiovascular effects of mexiletine for treatment of myotonia in myotonic dystrophy type 1

  Rafael Salguero-Bodes, Aníbal Ruiz-Curiel, Julián Palomino-Doza, María Valverde-Gómez, Cristina Domínguez-González, Fernando Arribas-Ynsaurriaga

  Rev Esp Cardiol. 2021;74:986-7

• Dilated cardiomyopathy and mild limb girdle muscular dystrophy caused by the p.Gly424Ser genetic variant in the fukutin gene

  José M. Larrañaga-Moreira, Patricia Blanco-Arias, Beatriz San Millán-Tejado, Gonzalo Barge-Caballero, María G. Crespo-Leiro, Roberto Barriales-Villa

  Rev Esp Cardiol. 2021;74:987-9

• Transcatheter closure of a vertical vein in a patient with total anomalous pulmonary venous drainage decompressing the left atrium with an AFR device

  Virginia Pascual-Tejerina, Ángel Sánchez-Recalde, Federico Gutiérrez-Larraya, José Ruiz-Cantador, Luis Rodríguez-Padial, José L. Zamorano

  Rev Esp Cardiol. 2021;74:990-1

• Leadless atrioventricular synchronous pacing: a validation pilot study with Holter monitoring

  Sem Briongos Figuero, Álvaro Estévez Paniagua, Ana Sánchez Hernández, Ane Abad-Motos, Alicia Ruiz, Roberto Muñoz-Aguilera

  Rev Esp Cardiol. 2021;74:992-3

• Temporal trends in hospitalization and in-hospital mortality rates due to heart failure by age and sex in Spain (2003-2018)

  Manuel Anguita Sánchez, Juan Luis Bonilla Palomas, María García Márquez, José Luis Bernal Sobrino, Francisco Javier Elola Somoza, Francisco Marín Ortuño

  Rev Esp Cardiol. 2021;74:993-6

• Prevalence and characteristics of clonal hematopoiesis in heart failure

  Laura Palomo, Evelyn Santiago-Vacas, Domingo Pascual-Figal, José Javier Fuster, Francesc Solé, Antoni Bayés-Genís

  Rev Esp Cardiol. 2021;74:996-9

• Complete resolution of atypical pericardial cyst after acute pleuropericarditis

  Carla Jiménez Martínez, Elena España Barrio, Ana Isabel Sanz Merino, Pablo Robles Velasco, Pilar Olmedilla Arregui, Raquel Campuzano Ruiz

  Rev Esp Cardiol. 2021;74:1110-2

• Cardiac magnetic resonance with 4D-flow in pre- and postcorrection assessment of partial anomalous pulmonary venous drainage

  Javier Urmeneta Ulloa, Jorge Rivas Oyarzabal, José Ángel Cabrera, Ana Álvarez Vázquez, Alberto Forteza Gil, Vicente Martínez de Vega

  Rev Esp Cardiol. 2021;74:1112-4

• Usefulness of a smartphone-based event recorder for ambulatory patients with palpitations

  María Eladia Salar Alcaraz, Francisco Buendía Santiago, Pedro José Flores Blanco, Arcadio García Alberola, Domingo Andrés Pascual Figal, Sergio Manzano Fernández

  Rev Esp Cardiol. 2021;74:1114-6

• Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction

  Laia Carla Belarte-Tornero, Diana Mojón, Eduard Solé-González, Sonia Ruiz-Bustillo, Sandra Valdivielso-More, Núria Farré

  Rev Esp Cardiol. 2021;74:1117-9

• Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine

  Almudena Ramírez-García, Sara Lozano Jiménez, Ignacio Darnaude Ximénez, Alberto Gil Cacho, Ramón Aguado-Noya, Javier Segovia Cubero

  Rev Esp Cardiol. 2021;74:1120-2

• Transcatheter mitral valve replacement with Tendyne: first experience in Spain

  Javier Cobiella Carnicer, Patricia Mahía Casado, Luis Nombela-Franco, Manuel Carnero Alcázar, Pilar Jiménez Quevedo, Luis Carlos Maroto Castellanos

  Rev Esp Cardiol. 2021;74:881-2

• Spontaneous spinal epidural hematoma associated with antiplatelet therapy with aspirin and ticagrelor

  Paula Vela Martín, Carolina Parra Esteban, Javier Ortega Marcos, Mario Carretero Rodrigo, Inés Lipperheide Vallhonrat, Lorenzo Silva Melchor

  Rev Esp Cardiol. 2021;74:883-4

• The role of genetics in pulmonary arterial hypertension associated with congenital heart disease

  Alejandro Cruz-Utrilla, Natalia Gallego, Teresa Segura de la Cal, Jair Tenorio-Castaño, Fernando Arribas-Ynsaurriaga, Pilar Escribano Subias

  Rev Esp Cardiol. 2021;74:884-6

• Percutaneous left atrial appendage closure in the presence of thrombus: a single-center experience

  Adolfo Fontenla, Ivan Gómez-Blázquez, Cecilia Corros-Vicente, Rafael Arboleda-Salazar, Rafael Salguero-Bodes, Fernando Arribas

  Rev Esp Cardiol. 2021;74:886-8

• Mid-term outcomes of percutaneous tricuspid annuloplasty with the Cardioband device

  Jorge Solano-López, José L. Zamorano, Ana García-Martín, Ariana González Gómez, Covadonga Fernández-Golfín, Ángel Sánchez-Recalde

  Rev Esp Cardiol. 2021;74:888-90

• Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

  Belén Álvarez-Álvarez, Teba González Ferrero, Mauro Trincado Ave, Alberto Cordero, Francisco Gude Sampedro, José R. González-Juanatey

  Rev Esp Cardiol. 2021;74:891-3

• Initial experience of an interhospital rescue program through a mobile extracorporeal membrane oxygenation team within a cardiology department

  Aitor Uribarri, Alexander Stepanenko, Javier Tobar, Carlos M. Veras-Burgos, Ignacio J. Amat-Santos, José A. San Román

  Rev Esp Cardiol. 2021;74:802-3

• Caval valve implantation for percutaneous treatment of tricuspid regurgitation: preprocedural anatomical assessment

  Sandra Santos-Martínez, Alfredo Redondo, Isabel San José Crespo, Teresa Sevilla, Hans R. Figulla, Ignacio J. Amat-Santos

  Rev Esp Cardiol. 2021;74:803-5

• Prognostic value of 3D area strain in moderate or severe aortic regurgitation with preserved ejection fraction

  Laura Morán Fernández, Eduardo Casas Rojo, Ana García Martín, José Luis Moya Mur, Covadonga Fernández Golfin, José Luis Zamorano Gómez

  Rev Esp Cardiol. 2021;74:805-7